Prasol Chemicals IPO Financials, Risk Factors, Peers & Objects of Issue
An investor-focused breakdown of the Prasol Chemicals IPO offer document: restated financial performance, key ratios, valuation across the price band, competitive strengths, risk factors, listed peers, objects of the issue and the business model, all drawn from the company's RHP disclosures.
Back to the Prasol Chemicals IPO report → (allotment, subscription, GMP)
Prasol Chemicals IPO Financial Performance (Restated)
On a restated consolidated basis, the company revenue increased by 22% and profit after tax (PAT) rose by 91% between the financial year ending with March 31, 2026, a useful one-line read on operating momentum heading into the listing.
Here is how the books have moved over the last three financial years:
31 Mar 2026 to 31 Mar 2024₹ Crore
All figures in ₹ Crore unless stated otherwise. Source: restated financials disclosed in the offer documents.
Profits have scaled from ₹18.13 Cr to ₹83.12 Cr over two years; the borrowings-to-net-worth ratio has eased to about 0.25. For investors, the trend matters more than any single year, steady compounding with contained leverage is what institutional bidders typically reward, while a late spike in borrowings deserves scrutiny against the stated objects of the issue.
Prasol Chemicals IPO Key Performance Indicators (KPI)
ROE20.37%
RoCE22.43%
Return on Net Worth18.53%
Debt / Equity0.19
NAV per share77.33
Reading these numbers. RoE and RoCE measure how efficiently the business turns shareholder capital into profit; anything in double digits is respectable, mid-twenties plus is strong. A debt-to-equity ratio well below 1 signals a balance sheet that does not depend on lenders. NAV per share anchors the book value of your bid, while price-to-book tells you how many rupees the issue is charging for each rupee of that book, compare it with listed peers in the same sector before deciding whether the premium is justified.
Prasol Chemicals IPO Competitive Strengths (as disclosed in the RHP)
Key strengths
- Largest importer of acetone in India during 2023-2025 and the only manufacturer of isophorone in India.
- Over 150 specialty chemical products, over 1,600 customers, and exports to 69 countries as of July 15, 2026.
- Among the top 5 users of yellow phosphorous in India during 2022-2025 for phosphorous-based specialty chemicals.
- Dedicated R&D team of 37 members (4 PhDs, 25 chemists) with 13 new products commercialized since April 1, 2023 and a pipeline of 40 products (9 cleared pilot stage).
- Government of India certified 3 Star Export House and Indian Customs certified Authorised Economic Operator with REACH and K-REACH registrations.
- Marquee customers include Alembic Pharmaceuticals, Croda India, Lubrizol India, and Gharda Chemicals; repeat customers contributed 93.28% of Fiscal 2026 revenue.
- Highly diversified product portfolio used across various Application Industries
- Well established R&D capabilities driving innovation with strong pipeline of products
- Long standing relationships with a diversified customer base and strong global presence
- Experienced, Qualified and Professional Leadership Team
Prasol Chemicals IPO Industry Snapshot
- Indian chemical industry market size grew from Rs 141.1 billion in FY19 to Rs 448.4 billion in FY29, driven by demand from manufacturing, agriculture, healthcare, and energy.
- Specialty chemicals share projected to rise from 20% in CY24 to 22% in CY25, reflecting increasing demand from automotive, construction, and personal care.
- Paints & Coatings Chemicals market to grow at CAGR 10% from Rs 41 Bn in FY26 to ~Rs 54 Bn by FY29, supported by real estate, industrial expansion, and automobile production.
- Construction Chemicals market to grow at CAGR 11% from Rs 32 Bn in FY22 to Rs 44 Bn in FY29, driven by public/private infrastructure investments and PMAY/smart city projects.
- Key government policies supporting the sector include Make in India, Atmanirbhar Bharat, National Chemical Policy, Chemical Sector Skill Development Council, PMAY, and PLI scheme.
- Import substitution trend: domestic production share rose from 40-50% in FY19 to >60% in FY26, while import share declined from 50-60% to 35-40%.
Prasol Chemicals IPO Listed Peers (per RHP)
Prasol Chemicals valuation versus listed peers in the same industry, from the RHP peer set. The highlighted This IPO column shows how the issue compares on P/E and return on net worth; green marks a cheaper multiple or a stronger ROE relative to the peer median.
Aarti Industries Limited
P/E (x)46.79
ROE (%)7.0
EPS (₹)—
Atul Limited
P/E (x)28.04
ROE (%)10.9
EPS (₹)—
Laxmi Organic Industries Limited
P/E (x)59.95
ROE (%)4.0
EPS (₹)—
Vinati Organic Limited
P/E (x)30.95
ROE (%)14.0
EPS (₹)—
Privi Speciality Chemicals Limited
P/E (x)42.67
ROE (%)22.0
EPS (₹)—
Yasho Industries Limited
P/E (x)206.68
ROE (%)5.7
EPS (₹)—
Excel Industries Limited
P/E (x)17.12
ROE (%)4.4
EPS (₹)—
This IPO Prasol Chemicals
P/E (x)—
ROE (%)20.4
EPS (₹)—
cheaper / strongerpricier P/Ebelow-median ROE
Prasol Chemicals IPO Objects of the Issue
Repayment and/or pre-payment, in full or part, of certain borrowings availed by the Company600.00
General corporate purposes (subject to not exceeding 25% of Gross Proceeds)[●]
Disclaimer: The financial data on this page is auto-extracted from the company's offer document (RHP/DRHP) and is provided for education only. DostIpo is not a SEBI-registered investment adviser; verify all figures against the official prospectus before making any investment decision. Investments in the securities market are subject to market risks.
View the complete Prasol Chemicals IPO report: allotment status, subscription, GMP & review →
Last updated: 03 Sep 2026, 09:08 IST